The analysis is examining several actions of efficacy also. With three month follow-up data in-hand, Cardio3 BioSciences has observed positive and encouraging trends in a number of physiological and clinical parameters. Meaningful differences were seen in ventricular size, ejection fraction and various other measures of heart muscles activity in C-Remedy treated patients when compared to control and to baseline. Partial data from a paired evaluation of patients at six-weeks follow-up can be suggestive of the beneficial tendencies being reinforced over time. Cardio3 Biosciences intends to create the study results after the complete six month dataset is available and offers been analysed. Dr Christian Homsy, CEO of Cardio3 BioSciences said: The info up to now from our trial is quite encouraging.Insulin resistance, blood pressure and oxidative tension decreased in the organizations consuming high and intermediate amounts also. Researchers believed about 40 % of the improvement in cognitive functions may be due to the increased insulin resistance. Some doctors are worried, however, that the total results may encourage visitors to each chocolate, which can be high in fat and calorie consumption. Dr. Sam Gandy, the Mount Sinai chair in Alzheimer’s disease study at Mount Sinai School of Medicine in NY, informed WebMD that he still believes 30 minutes of exercise at least 3 x a week is much better than any amount of flavonoids consumed for brain health.